On the evening of April 15, HRH Prince Turki Alfaisal, Acting Chairman of the Board of Trustees of King Faisal Foundation, and King Faisal Prize Secretary General Dr. Abdulaziz Alsebail took the stage ...
Clinical trials suggest that about 10% to 15% of people who try GLP-1s don't lose weight. But evidence is building that shows ...
Websites selling compounded versions of GLP-1 drugs are not allowed to use the FDA-approved brand names of products like ...
PHILADELPHIA - A new study from the University of Pennsylvania suggests that artificial intelligence may help identify ...
Updates GLP drugs pricing and access highlight new subscription models, FDA approvals, and tighter regulatory oversight in 2024.
Q4 FY2025 earnings call highlights: comps +0.7%, EBITDA $903M, FY26 EPS/EBITDA outlook, IRA pharmacy headwinds & buybacks—read now.
Author Emma Copley Eisenberg used a class-action settlement against artificial intelligence to promote body positivity and her new book.
An AI study analyzing more than 400,000 Reddit posts identified patient-reported symptoms associated with GLP-1 medications ...
Morning Overview on MSN
America’s GLP-1 playbook shifts as pills and coverage reshape demand
For years, the only way to take a GLP-1 weight-loss drug was to inject it. That changed in late 2025, when the FDA cleared a ...
By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results